United Therapeutics CEO Martine A. Rothblatt reports $5.72 million common share sale
UTHR•United Therapeutics CEO Martine A. Rothblatt sold 9,500 common shares on Nov. 3, 2026, for weighted-average prices ranging from $598.676 to $605.97 per share. She also exercised options for 9,500 shares at $117.76, and the trust held 324,443 shares after the sales.
1. Share transactions
Rothblatt sold 9,500 United Therapeutics common shares on Nov. 3, 2026, at weighted-average prices ranging from $598.676 to $605.97 per share. On the same date, she exercised stock options for 9,500 common shares at $117.76 per share. The trust holdings involved in the transactions stood at 324,443 common shares following the sales.
